AstraZeneca to invest $50 billion in the U.S. as pharma tariffs weigh

Databricks told investors and analysts on Wednesday that annualized revenue will hit $3.7 billion by July, with 50% year-over-year growth.

The major averages ended Thursday on a sour note as an attempt to extend the Fed-fueled rally fell short.

Home sales in March were weaker than expected, due to higher mortgage rates and concern over the broader economy.